Bruce Frank

Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization.

E. El-Omar, J. Ekeruche-Makinde, G. Murray, 2016, The Journal of antimicrobial chemotherapy.

In vivo modulation of cervicovaginal drug transporters and tissue distribution by film-released tenofovir and darunavir for topical prevention of HIV-1.

C. Kelly, G. Pozzi, F. Iannelli, 2020, Molecular pharmaceutics.

Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial.

J. Billingsley, J. Marrazzo, A. Mcginn, 2019, The Lancet HIV.

A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring

Y. Lo, C. Hendrix, M. Marzinke, 2016, AIDS.

Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis

Sung Hyun Park, Jonathan T. Su, I. Szleifer, 2015, Antimicrobial Agents and Chemotherapy.

Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya

J. Baeten, R. Heffron, G. Doncel, 2022, Scientific Reports.

Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics.

N. Cheshenko, B. Herold, D. Fredricks, 2018, JCI insight.

Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis

Sung Hyun Park, Jonathan T. Su, I. Szleifer, 2015, Antimicrobial Agents and Chemotherapy.